SCHEMBL2459263

SCHEMBL2459263

c1nc2ccc(-c3cnon3)cc2[nH]1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
QPCT Q16769 10/20 0.51
QPCTL Q9NXS2 5/20 0.51
BRD4 O60885 1/20 0.51
CREBBP Q92793 1/20 0.51
PSMD11 O00231 1/20 0.48
KDM4E B2RXH2 3/20 0.47
NPC1 O15118 2/20 0.47
ALDH1A1 P00352 2/20 0.47
TP53 P04637 2/20 0.47
RAB9A P51151 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
HPGD P15428 1/20 0.47
PRKCI P41743 2/20 0.46
MAPT P10636 2/20 0.45
RAD52 P43351 1/20 0.45
S1PR1 P21453 1/20 0.44
MMP12 P39900 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2455150 0.87 KDM4E (0.41) QPCTQPCTLBRD4CREBBPPSMD11
SCHEMBL8634290 0.78 QPCT (0.68) QPCTQPCTLBRD4CREBBPPSMD11
SCHEMBL2459898 0.75 BRD4 (0.52) QPCTQPCTLBRD4CREBBPPSMD11
SCHEMBL2463930 0.74 QPCT (0.55) QPCTQPCTLBRD4CREBBPPSMD11
SCHEMBL2458235 0.73 PSMD11 (0.53) QPCTQPCTLBRD4CREBBPPSMD11
SCHEMBL2459152 0.72 BRD4 (0.50) BRD4KDM4EALDH1A1HPGDS1PR1
SCHEMBL2457588 0.72 ACVR1 (0.64) QPCTQPCTLBRD4CREBBPPSMD11
SCHEMBL2474515 0.72 QPCT (0.60) QPCTQPCTLBRD4CREBBPPSMD11
SCHEMBL2460632 0.71 FGFR1 (0.54) KDM4EALDH1A1MAPT
SCHEMBL2460276 0.71 QPCT (0.51) QPCTQPCTLBRD4CREBBPPSMD11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110237633-A1 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2011-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237633-A1 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY HGF, HDGF, MET QPCT 3492/4885QPCTL 4285/4885BRD4 3654/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.